6:28 PM
 | 
Jan 15, 2013
 |  BC Extra  |  Politics & Policy

Four biotechs form advocacy group for antibiotics

Four biotech companies formed the Antibiotics Working Group (AWG) to lobby Congress and FDA on commercial, regulatory and reimbursement policies that could facilitate the development of new antibacterial drugs. The biotechs are

Read the full 145 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >